Company Profile

AxioMx Inc
Profile last edited on: 9/19/19      CAGE: 6PHK4      UEI: LVKMZCPAKSU9

Business Identifier: Recombinant antibody technologies
Year Founded
First Award
Latest Award
Program Status
Inactive (Acquired)
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

688 East Main Street
Branford, CT 06405
   (203) 208-1918
Location: Single
Congr. District: 03
County: New Haven

Public Profile

In November 2015 it was announced that Abcam plc would acquire AxioMx, Inc. The firm had been involved in discovery, development, production, and delivery of recombinant antibodies against the human proteome. It also offers custom recombinant antibody discovery and development services ranging from peptide synthesis to large-scale antibody production. The company's services include antigen and peptide synthesis, epitope mapping, phage display library screening and affinity maturation, and custom phage display library development; and antibody design, modification, optimization, and production. In addition, AxioMx, Inc. offers a range of custom antibody discovery and development services for the research and diagnostic market places. The company's recombinant antibodies are used in western blotting, ELISAs, flow cytometry, immunohistochemistry, and immunoprecipitation applications. Founder principals are life science entrepreneurs having previously led successful genomics, next-generation sequencing, microfluidics, bioinformatics and proteomic organizations. AxioMx’s unique platform of proprietary phage display libraries, library screening, and affinity maturation methods provides the technical foundation of the company. The company offers a full range of custom antibody discovery and development services for the research and diagnostic market places.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  Christopher Mcleod -- Founder, President and CEO

  Dawn Alderman -- Director Of Automation & Production

  Margaret Kiss -- Director, Molecular Sciences

  Tom Thompson -- Vice President Of Sales & Marketing

  Janet Verney -- Executive Director

  Michael P Weiner -- Founder: Consultant, Application Development

  Michael P Weiner -- CSO & Founder